• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.40% Nasdaq Up 0.94%

    Celgene Corporation (CELG)

    -NasdaqGS
    100.22 Up 0.64(0.64%) 2:02PM EST - Nasdaq Real Time Price
    Prev Close:99.59
    Open:100.99
    Bid:100.34 x 100
    Ask:100.41 x 100
    1y Target Est:139.29
    Beta:1.86499
    Earnings Date:Apr 28 - May 2 (Est.)
    Day's Range:97.46 - 101.00
    52wk Range:92.98 - 140.72
    Volume:3,700,793
    Avg Vol (3m):6,087,620
    Market Cap:78.74B
    P/E (ttm):51.66
    EPS (ttm):1.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 0.64%78.74B
    JNJDown 0.37%280.35B

    Key Statistics

    Forward P/E (1 yr):13.90
    P/S (ttm):8.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.72
    Quarterly EPS Est (Mar-16) :1.28
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.77

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback